Wysa Receives FDA Breakthrough Device Designation for AI-led Mental Health Conversational Agent
New peer-reviewed studies demonstrate efficacy in managing chronic pain, depression, and anxiety BOSTON, USA, May 12, 2022 – Wysa, a leading artificial intelligence (AI) based